Presentation Developed for the Academy of Managed Care Pharmacy

Slides:



Advertisements
Similar presentations
Donna A. Messner, PhD Research Director Center for Medical Technology Policy.
Advertisements

©PPRNet 2014 Impact of Patient Engagement on Treatment Decisions and Patient-Centered Outcomes in the Implementation of New Guidelines for the Treatment.
1 Day of Research and Engagement for the Community Markham, IL March 1, 2014 Aingyea Kellom, MPA Program Associate, Patient Engagement Ambassador Program.
Engaging Patients and Other Stakeholders in Clinical Research
Introduction to the User’s Guide for Developing a Protocol for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research.
Value & Coverage Issue Brief Slides A Closer Look at Health Plan Coverage Policies and Approaches.
The Community Engagement Studio: Strengthening Research Capacity through Community Engagement Consuelo H. Wilkins, MD, MSCI Executive Director, Meharry.
Shared Decision-making’s Place in Health Care Reform Peter V. Lee Executive Director National Health Care Policy, PBGH Co-Chair, Consumer-Purchaser Disclosure.
The SHARE Approach Essential Steps of Shared Decision Making
Knowing What Works in Health Care : A Roadmap for the Nation Alliance for Health Reform April 4, 2008 Wilhelmine Miller, MS, PhD GWU SPHHS.
So You Want to Do Comparative Effectiveness Research? The Nuts and Bolts of CER.
RTI-UNC EPC Issues Exploration Forum (IEF):. Serious Mental Illness Dan Jonas, MD, MPH.
Building Public Health / Clinical Health Information Exchanges: The Minnesota Experience Marty LaVenture, MPH, PhD Director, Center for Health Informatics.
Critical Appraisal of Clinical Practice Guidelines
COMPARATIVE EFFECTIVENESS RESEARCH Public Policy Interest and Issues Jeanne Lambrew, PhD Associate Professor LBJ School of Public Affairs National Health.
1 NATIONAL ADVISORY COUNCIL ON HEALTHCARE RESEARCH AND QUALITY Subcommittee on Quality Measures for Children's Healthcare in Medicaid and CHIP Overview.
Stakeholder Engagement and Transparency in The Effective Health Care Program Supriya Janakiraman MD MPH AHRQ.
AHRQ’s Role in Comparative Effectiveness Carolyn M. Clancy, MD Director Agency for Healthcare Research and Quality Alliance for Health Reform Briefing.
1 Evidence and the next stage of health care reform: Why consumer engagement is so important Steven D. Pearson, MD, MSc President, Institute for Clinical.
Joe Selby, MD MPH EBRI December 15, 2011 What Might Patient (Employee)- Centered Research Look Like?
Putting the Patient at the Center of Health Care Research Joe Selby, MD, MPH Executive Director, Patient-Centered Outcomes Research Institute The Conference.
The Culture of Healthcare Evidence-Based Practice Lecture a This material (Comp2_Unit5a)was developed by Oregon Health and Science University, funded by.
ARRA and HHS Data Policy Initiatives Academy Health NAHDO All Payer All Claims Data Bases James Scanlon, HHS Deputy Assistant Secretary/ASPE.
Access to Personalised Medicine for PDAC patients STSM of the application of an EU-index for barriers Denis Horgan (EAPM) & Angela Brand (IPHG) on behalf.
Secondary Translation: Completing the process to Improving Health Daniel E. Ford, MD, MPH Vice Dean Johns Hopkins School of Medicine Introduction to Clinical.
Improving Value in Health Care: Challenges and Potential Strategies Arnold M Epstein October 24, 2008 Congressional Health Care Reform Education Project.
Presentation to the SAMHSA Advisory Councils
Introduction to Healthcare and Public Health in the US Introduction and History of Modern Healthcare in the US Lecture c This material (Comp1_Unit1c) was.
Health Information Technology Summit John Tooker, MD, MBA, FACP Executive Vice President/CEO American College of Physicians Washington, DC October 21,
Medicaid/SCHIP Technical Assistance for Health IT/HIE 2008 AHRQ Annual Conference Presented by: Linda Dimitropoulos, RTI International.
Evidence-Based Medicine Introduction Component 2/Unit 5 1 Health IT Workforce Curriculum Version 1.0 /Fall 2010.
Stakeholder Engagement for Patient-Centered Outcomes Research Vanessa Jacoby, MD, MAS Associate Professor Obstetrics, Gynecology, and Reproductive Sciences.
Component 1: Introduction to Health Care and Public Health in the U.S. 1.9: Unit 9: The evolution and reform of healthcare in the US 1.9c: Quality Indicators.
Technology, Information Systems and Reporting in Pharmacy Benefit Management Presentation Developed for the Academy of Managed Care Pharmacy Updated: February.
The History of Managed Care Organizations in the United States Presentation Developed for the Academy of Managed Care Pharmacy Updated February 2015.
Presentation Developed for the Academy of Managed Care Pharmacy
Comparative Effectiveness Research (CER) and Patient- Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
PRAGMATIC Study Designs: Elderly Cancer Trials
The History of Managed Care Organizations in the United States
Home Based Palliative Care
Developing a guideline
Module 3: Orientation to Research
Patient-Oriented Research 101
Patient Involvement in the HTA Decision Making Process
Clinical Studies Continuum
Leigh E. Tenkku, PhD, MPH Department of Family and Community Medicine
Hematopoietic Cell Transplantation: Moving Beyond Survival to the Patient’s Perspective Linda J Burns, MD Medical Director, NMDP/Be The Match Health.
Systematic Reviews and Medical Policy Determinations
Clinical & Translational Science Institute 11/12/2018
Value of Pharmaceuticals in Managed Care Pharmacy
Presentation Developed for the Academy of Managed Care Pharmacy
Pharmacists Optimizing Cancer Care
Certified Professional Patient Navigator CPPN
Provider and Member Education in Managed Care Pharmacy
Jason Gerson, PhD Clinical Effectiveness and Decision Science
PCORI Research Priorities and Relevant Examples
Accountable care organizations
Clinical and Translational Science Awards Program
Provider Peer Grouping: Project Overview
For PUBLIC SECTOR HEALTHCARE ROUNDTABLE NOVEMBER 2, 2017
Module 5: Formulating Research Questions
Health Services for Individuals that are Deaf and Hard of Hearing
Regulatory Perspective of the Use of EHRs in RCTs
Evidence-Based Public Health
Patient-Centered Outcomes Research Institute (PCORI)
SAMPLE ONLY Dominion Health Center: Your Community Healthcare Home (or another defining message) Dominion Health Center is a community health center.
Getting to the Results that Matter
Presentation Developed for the Academy of Managed Care Pharmacy
Presentation transcript:

Presentation Developed for the Academy of Managed Care Pharmacy Comparative Effectiveness Research (CER) and Patient-Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy Updated February 2014

Topics Covered Background Definitions Goals of CER and PCOR Stakeholders Funding sources Challenges CER study design and user tools

Background Early draft of the Affordable Care Act (ACA) included provisions for comparative effectiveness research (CER). “CER” changed to “Patient-Centered Outcomes Research” in legislation based on voter input Many entities view terms as interchangeable; however, the definitions do differ ACA established a Patient-Centered Outcomes Research Institute (PCORI) Funded through the general fund of the US treasury and in small part by assessments on Medicare, private health insurance, and self-insured plans.

Definitions CER and PCOR are not synonymous CER Includes any type of medical or pharmaceutical intervention (e.g. lab tests, procedures, medications, etc.) Institutes of Medicine (IOM): generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care. Kaiser Family Foundation: compares two or more different methods for preventing, diagnosing, and treating health conditions. Such research is performed using methods such as practical clinical trials, analyses of claims records, computer modeling, and systematic reviews of existing literature.

Definitions PCOR PCORI’s working definition states that PCOR: Assesses the benefits and harms of preventive, diagnostic, therapeutic, palliative, or health delivery system interventions to inform decision making, highlighting comparisons and outcomes that matter to people; Is inclusive of an individual’s preferences, autonomy and needs, focusing on outcomes that people notice and care about such as survival, function, symptoms, and health related quality of life; Incorporates a wide variety of settings and diversity of participants to address individual differences and barriers to implementation and dissemination; and Investigates (or may investigate) optimizing outcomes while addressing burden to individuals, availability of services, technology, and personnel, and other stakeholder perspectives.

Goals of CER and PCOR CER and PCOR definitions differ, but goals are similar CER: IOM: assist consumers, clinicians, purchasers, and policy makers to make informed decisions that will improve health care at both the individual and population levels. Kaiser Family Foundation: improve health outcomes by developing and disseminating evidence based information to patients, providers, and health care decision-makers about the effectiveness of treatments relative to other options. Identifying the most effective and efficient interventions has the potential to reduce unnecessary treatments, which in turn, may help lower costs. PCOR: PCORI: help people and their caregivers communicate and make informed healthcare decisions, allowing their voices to be heard in assessing the value of healthcare options.

Stakeholders Patients: Providers: Managed care organizations: Understand risks/benefits of treatment options Make informed healthcare decisions Providers: Make informed treatment recommendations Facilitate patient-shared decision-making Managed care organizations: Support benefit/formulary changes Educate members and providers United States Healthcare System Improve health of U.S. population Decrease variability in clinical practice across the country Decrease healthcare costs

Funding Sources To date, most CER and PCOR projects have been funded through grants PCORI Awards research grants for PCOR from federal funds US Department of Health & Human Services (HHS) Agency for Healthcare Research and Quality (AHRQ) Funding to train researchers to conduct CER and PCOR has been provided by The PhRMA Foundation

Challenges CER and PCOR require special skill sets: Researchers Focus on new approaches to research to inform decision making by patients and caregivers Educators Training researches to conduct CER and PCOR Clinical decision-makers and Assessing the validity and applicability of CER and PCOR output Interpreting and applying the resulting body of evidence Policy-makers Establish policy based on a body of evidence that is valid and applicable to their population Payers Make payment decisions based on the most effective treatment options based on individual patient characteristics

CER Study Design and User Tools Individual studies: Prospective randomized or observational trials Retrospective observational trials Indirect treatment comparisons Network meta-analyses Modeling studies Evaluate the overall body of evidence User tools: AMCP/ISPOR/NPC collaborative: www.cercollaborative.org AMCP CER Certificate Program

AMCP CER Certificate Program Advance evidence assessment expertise with new research designs and study data Learn about tools to help assess current questions in real-world settings Certificate Program Details 19 Credit Hours Five - Online Modules One – 4 hour workshop – with live presentations at one of AMCP’s national meetings Student Fee $400 Additional information about the CER Certificate Program can be found on the AMCP website under “Professional Practice” and “Formulary Decision Support Tools”

References Patient-Centered Outcomes Research Institute (website). Accessed on: March 21, 2014. Available at: http://www.pcori.org/ Selby JV, Beal AC, Frank L. The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda. JAMA. 2012 Apr;307(15):1583-4. Institutes of Medicine. Initial national priorities for comparative effectiveness research. June 30, 2009. Accessed on: March 21, 2009. Available at: http://www.iom.edu/Reports/2009/ComparativeEffectivenessResearchPriorities.aspx The Henry J. Kaiser Family foundation. Explaining health reform: what is comparative effectiveness research? October 2009. Accessed on: March 21, 2014. Available at: http://kff.org/health-costs/issue-brief/explaining-health-care-reform-what-is-comparative/

Thank you to AMCP members Carly Rodriguez and Cheryl Kaltz for creating this slide deck.